Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Investigation launched into ADMA Biologics over alleged revenue inflation and channel stuffing claims
ADMA
$8.86
+$0.18 +2.07%

Investigation launched into ADMA Biologics over alleged revenue inflation and channel stuffing claims

Market News
27 Mar 2026
Newsfile Corp
View Source
Bearish
pluang ai news

Levi & Korsinsky has started an investigation into ADMA Biologics following allegations by Culper Research that the company inflated ASCENIV's revenue growth through channel stuffing. ADMA reported 51% year-over-year revenue growth for ASCENIV in Q4 2025, but Culper claims actual demand is declining, citing distributor feedback. This discrepancy led to a sharp drop in ADMA's stock price after the short-seller report was published. Investors who suffered losses may seek recovery under federal securities laws as the investigation unfolds.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App